Clinical Trial

Enlighten Study: The EV-ICD Post Approval Registry

Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
Medtronic is sponsoring Enlighten: The EV-ICD Post Approval Registry, to further confirm safety and effectiveness of EV-ICD in routine clinical practice, following commercial release of EV-ICD devices.
Protocol Amendment History 18 amendments
This ClinicalTrials.gov record has been amended 18 times since 2023-09-20; most recent amendment 2025-07-28.
Status change: Recruiting → Active, Not Recruiting 2025-03-11
Trial Details
NCT Number NCT06048731
Lead Sponsor Medtronic
Conditions Ventricular Arrhythmia, Tachycardia
Enrollment 1,000 participants
Start Date 2023-09-01
Primary Completion 2030-05-31 (estimated)
Study Completion 2037-10-31 (estimated)
Updated on ClinicalTrials.gov 2025-07-30